- cafead Dec 17, 2021 at 12:22: AM
via Ever since federal officials briefly halted Johnson & Johnson's COVID-19 vaccine rollout this spring, the shot has seen limited use in the U.S. Now, the program is hitting another major setback.
Citing new data on the risk of potentially deadly blood clots associated with the J&J shot, Centers for Disease Control and Prevention (CDC) vaccine advisers have recommended use of mRNA shots from Pfizer and Moderna over J&J's vaccine, The Washington Post reports.
article source
Citing new data on the risk of potentially deadly blood clots associated with the J&J shot, Centers for Disease Control and Prevention (CDC) vaccine advisers have recommended use of mRNA shots from Pfizer and Moderna over J&J's vaccine, The Washington Post reports.
article source